SCHEMBL296120

SCHEMBL296120

CCCCNC1(c2nc(Cl)nc(C3(NCCCC)CC(C)(C)NC(C)(C)C3)n2)CC(C)(C)NC(C)(C)C1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL296486 0.97 KMT2A (0.31) KMT2A
SCHEMBL7005271 0.77
SCHEMBL8399541 0.74
SCHEMBL1249673 0.69 KDM4E (0.42) KMT2A
SCHEMBL28632316 0.65 TSHR (0.30)
Hexane SCHEMBL28831334 0.58 TSHR (0.53) KMT2A
SCHEMBL987508 0.57 KMT2A (0.66) KMT2A
SCHEMBL2783761 0.57 KMT2A (0.71) KMT2A
Ammonia Solution, Strong SCHEMBL16679627 0.57 SLC2A1 (0.43) KMT2A
SCHEMBL14696364 0.55 GRIN1 (0.68)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138350-A1 Stabilized metallocene polyolefins BASF AKTIENGESELLSCHAFT (DE) 2004-07-15 US claimed
EP-4731727-A1 HALF-WAVE PLATE Merck Patent GmbH (DE) 2026-04-29 EP disclosed
EP-4713413-A1 CHIRAL REACTIVE MESOGEN MIXTURE Merck Patent GmbH (DE) 2026-03-25 EP disclosed
EP-4713414-A1 OPTICAL ELEMENT COMPRISING A CHIRAL LC POLYMER FILM Merck Patent GmbH (DE) 2026-03-25 EP disclosed
US-20260071126-A1 Polymerizable Liquid Crystal Material and Polymerized Liquid Crystal Film MERCK PATENT GMBH (DE) 2026-03-12 US disclosed
US-12570900-B2 Polymerisable compound, polymerisable LC material and polymer film MERCK PATENT GMBH (DE) 2026-03-10 US disclosed
US-12565617-B2 Polymerisable oligomeric liquid crystal, polymerisable medium and polymerised liquid crystal film MERCK PATENT GMBH (DE) 2026-03-03 US disclosed
EP-4689004-A1 CHIRAL REACTIVE MESOGEN MIXTURE Merck Patent GmbH (DE) 2026-02-11 EP disclosed
EP-4689002-A1 REACTIVE MESOGENS WITH HIGH BIREFRINGENCE Merck Patent GmbH (DE) 2026-02-11 EP disclosed
US-20250361445-A1 POLYMERISABLE LIQUID CRYSTAL MEDIUM AND POLYMERISED LIQUID CRYSTAL FILM MERCK PATENT GMBH (DE) 2025-11-27 US disclosed
EP-1155098-B1 LIQUID CRYSTALLINE SUBSTANCE MIXTURES BASF AG (DE) 2004-05-26 EP disclosed
US-6737527-B2 IN PARTICULAR FOR STABILIZING PLASTICS OR COATING MATERIALS; PHOTOSTABILITY BASF AKTIENGESELLSCHAFT (DE) 2004-05-18 US disclosed
US-6733689-B1 ACRYLIC ESTER AND VINYL ETHER LIQUID CRYSTAL POLYMERS BASF DRUCKSYSTEME GMBH (DE) 2004-05-11 US disclosed
US-20040010092-A1 Method for the preparation of a polyester block copolymer, a polyester block copolymer composition and method for the preparation thereof WATANABE JUN (JP) 2004-01-15 US disclosed
US-6593434-B1 Condensation polymerization, esterification, melt mixing or kneading; high molecular weight, low crystallinity DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2003-07-15 US disclosed
US-20030083406-A1 4-Formyl amino-n-methylpiperidine derivatives, the use thereof as stabilisers and organic material stabilised therewith BASF AKTIENGESELLSCHAFT (DE) 2003-05-01 US disclosed
US-20030060544-A1 Stabilizer composition BASF AKTIENGESELLSCHAFT (DE) 2003-03-27 US disclosed
EP-1120432-A1 PROCESS FOR THE PRODUCTION OF POLYESTER BLOCK COPOLYMERS, POLYESTER BLOCK COPOLYMER COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) 2001-08-01 EP disclosed
US-6214929-B1 FREE RADICAL POLYMERIZATION OF AN ETHYLENICALLY UNSATURATED MONOMER BASF AKTIENGESELLSCAFT (DE) 2001-04-10 US disclosed
EP-0942037-A1 Polymer dispersions or solutions containing stabilisers and polymer preparations obtainable therefrom BASF AKTIENGESELLSCHAFT (DE) 1999-09-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030083406-A1 4-Formyl amino-n-methylpiperidine derivatives, the use thereof as stabilisers and organic material stabilised therewith PNMT, INMT, AZI2 KMT2A 287/4885
US-12570900-B2 Polymerisable compound, polymerisable LC material and polymer film L3MBTL3, L3MBTL1, L3MBTL4 KMT2A 1566/4885
US-20260071126-A1 Polymerizable Liquid Crystal Material and Polymerized Liquid Crystal Film MLX, SCO2, VCL KMT2A 1591/4885
US-12565617-B2 Polymerisable oligomeric liquid crystal, polymerisable medium and polymerised liquid crystal film NOD1, OSTC, MLX KMT2A 4456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.